問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
蔡承翰
下載
2025-04-01 - 2027-12-31
Condition/Disease
Metastatic castration-resistant prostate cancer (mCRPC)
Test Drug
BMS-986365 (CC-94676)
Participate Sites4Sites
Recruiting4Sites
2024-10-01 - 2035-12-31
Participate Sites3Sites
Not yet recruiting1Sites
Recruiting2Sites
2024-11-01 - 2031-09-30
Participate Sites5Sites
Recruiting5Sites
2025-08-01 - 2035-08-31
Participate Sites6Sites
Recruiting6Sites
2024-10-01 - 2029-09-30
2025-09-01 - 2029-12-31
Participate Sites7Sites
Recruiting7Sites
2026-06-01 - 2030-12-31
2025-04-15 - 2032-12-31
Participate Sites2Sites
2024-01-01 - 2031-12-31
2023-10-31 - 2035-12-31
全部
